دورية أكاديمية
174P Safety and efficacy of anlotinib plus docetaxel in advanced non-small cell lung cancer patients after failure of first-line chemotherapy: Recent results from the ongoing phase II study (ALTER-L024)
العنوان: | 174P Safety and efficacy of anlotinib plus docetaxel in advanced non-small cell lung cancer patients after failure of first-line chemotherapy: Recent results from the ongoing phase II study (ALTER-L024) |
---|---|
المؤلفون: | Jin, B., Wang, G., Zhang, Y.L., Wu, R., Chen, J., Dong, Y., Peng, L.Y. |
المصدر: | Journal of Thoracic Oncology ; volume 16, issue 4, page S793 ; ISSN 1556-0864 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2021 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
مصطلحات موضوعية: | Pulmonary and Respiratory Medicine, Oncology |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/s1556-0864(21)02016-5 |
الإتاحة: | https://doi.org/10.1016/s1556-0864Test(21)02016-5 https://api.elsevier.com/content/article/PII:S1556086421020165?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S1556086421020165?httpAccept=text/plainTest |
حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
رقم الانضمام: | edsbas.C40186A2 |
قاعدة البيانات: | BASE |
DOI: | 10.1016/s1556-0864(21)02016-5 |
---|